Cargando…
Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway
The usefulness of circulating proprotein convertase subtilisin-kexin type 9 (PCSK9) as a risk marker of coronary heart disease in the general population remains unclear. In a nested case-control study in Norway, 1,488 incident myocardial infarctions were registered during 11.3 years of follow-up and...
Autores principales: | Laugsand, Lars E., Åsvold, Bjørn O., Vatten, Lars J., Janszky, Imre, Platou, Carl G., Michelsen, Annika E., Damås, Jan K., Aukrust, Pål, Ueland, Thor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113535/ https://www.ncbi.nlm.nih.gov/pubmed/30167541 http://dx.doi.org/10.1016/j.jacbts.2016.06.007 |
Ejemplares similares
-
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
por: Ueland, Thor, et al.
Publicado: (2018) -
Mannose-Binding Lectin Deficiency Is Associated with Myocardial Infarction: The HUNT2 Study in Norway
por: Vengen, Inga Thorsen, et al.
Publicado: (2012) -
Insomnia and Endothelial Function – The HUNT 3 Fitness Study
por: Strand, Linn B., et al.
Publicado: (2012) -
Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study
por: Gustad, Lise Tuset, et al.
Publicado: (2014) -
Symptoms of anxiety and depression and risk of heart failure: the HUNT Study
por: Gustad, Lise T, et al.
Publicado: (2014)